Latest from BCA Research
Our Portfolio Allocation Summary for January 2025.
The US High-Quality (USHQ) portfolio slightly outperformed in January, returning 3.4%, whilst its SPY benchmark returned 2.9%. That said, we think the USHQ portfolio will have a solid run through the first half of 2025, benefitting from rising market risk on the back of President Trump’s tariff agenda. USHQ’s underlying Quality and Safety Score factor tilts will be increasingly favored as market uncertainty grows.
This Insight is a post mortem on Canadian assets, after the threat of tariff wars.
We revisit our view on the “fiscal gravy train” as well as President Trump’s negotiating style. We re-print parts of our March 2024 net assessment, particularly for the benefit of our new clients who have joined us at BCA Research. Our analysis of President Trump’s first term is our guide into how the White House will negotiate future trade wars and skirmishes.
Trump’s territorial ambitions threaten to deliver negative surprises and “black swan” risks during his four-year term. Military conflicts on the Mexican border raise the biggest risk, but US intervention in Panama can never be ruled out. The investment impact will be limited unless the trans-Atlantic alliance is damaged.
We expect market volatility to remain elevated due to uncertain economic, monetary, and trade policies. Barbell is the best portfolio strategy at this time. We recommend boosting defensive allocations to lower portfolio beta. We downgrade Industrials to equal weight and upgrade Pharma to overweight.
The 10% tariff hike announced on Saturday will likely serve as the opening salvo in a broader wave of protectionist measures. In this report, we assess the increase in US import tariffs on China. While the direct impact on China’s overall economy may be manageable, the country’s economy faces significant risks from potential disruptions in global trade.